Rxivist logo

Author: Hana Hastor

  • Most recently observed institution: Clinical Study Center (CSC), Berlin Institute of Health, and Charité - Universitä tsmedizin Berlin, Corporate Member of Freie Universitä t Berlin, Humboldt-Universitä t Zu Berlin, Campus Charité Mitte, Charitéplatz 1, 1


Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1-nCoV19 and BNT162b2: a prospective cohort study

infectious diseases more details view paper

No download data for this paper yet.